comparemela.com

Latest Breaking News On - Nrx pharma - Page 3 : comparemela.com

NRx Pharma Says Class Action Suit Against Company Dismissed

(RTTNews) - NRx Pharmaceuticals Inc. (NRXP) said Wednesday that on June 13, 2022, the plaintiffs in the securities class action lawsuit captioned .

United statesNrx pharmaDal boscoUs district courtNrx pharmaceuticals inc

NRx Pharma Files New Breakthrough Therapy Designation Request For ZYESAMI

(RTTNews) - NRx Pharmaceuticals, Inc. (NRXP) has filed a new Breakthrough Therapy designation request with the FDA focused on a subgroup of patien.

Nrx pharmaRobert besthofNrx pharmaceuticalsNrx pharmaceuticals incBreakthrough therapy

MONDAY DEADLINE: NRx Pharmaceuticals, Inc Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit

/PRNewswire/ Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP; NRXPW) securities between.

San diegoUnited statesRobbins gellerNrx pharmaDal boscoEnron corpDrug administrationPrnewswire robbins geller rudman dowdNrx pharmaceuticals incRobbins geller rudman dowdSecurities class action services topSecurities exchangeSecurities exchange actEmergency use authorizationClass periodPrivate securities litigation reform act

MONDAY DEADLINE: NRx Pharmaceuticals, Inc Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit

/PRNewswire/ Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP; NRXPW) securities between.

San diegoUnited statesRobbins gellerNrx pharmaDal boscoEnron corpDrug administrationPrnewswire robbins geller rudman dowdNrx pharmaceuticals incRobbins geller rudman dowdSecurities class action services topSecurities exchangeSecurities exchange actEmergency use authorizationClass periodPrivate securities litigation reform act

DEADLINE APPROACHING: NRx Pharmaceuticals, Inc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

/PRNewswire/ Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP; NRXPW) securities between.

San diegoUnited statesRobbins gellerNrx pharmaDal boscoEnron corpRobbins geller rudman dowdSecurities class action services topSecurities exchangeDrug administrationNrx pharmaceuticals incRobbins geller rudmanSecurities exchange actEmergency use authorizationClass periodPrivate securities litigation reform act

vimarsana © 2020. All Rights Reserved.